These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Tarng DC, Huang TP, Chen TW, Yang WC. Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294 [Abstract] [Full Text] [Related]
4. Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients. DeVita MV, Frumkin D, Mittal S, Kamran A, Fishbane S, Michelis MF. Clin Nephrol; 2003 Nov; 60(5):335-40. PubMed ID: 14640239 [Abstract] [Full Text] [Related]
8. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure. Ahluwalia N, Skikne BS, Savin V, Chonko A. Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369 [Abstract] [Full Text] [Related]
9. Subcutaneous versus intravenous administration of erythropoietin improves its efficiency for the treatment of anaemia in haemodialysis patients. Albitar S, Meulders Q, Hammoud H, Soutif C, Bouvier P, Pollini J. Nephrol Dial Transplant; 1995 Oct; 10 Suppl 6():40-3. PubMed ID: 8524493 [Abstract] [Full Text] [Related]
10. The role of iron in erythropoiesis in the absence and presence of erythropoietin therapy. Goodnough LT. Nephrol Dial Transplant; 2002 Oct; 17 Suppl 5():14-8. PubMed ID: 12091601 [Abstract] [Full Text] [Related]
11. The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (i.v. or s.c.). De Schoenmakere G, Lameire N, Dhondt A, Van Loo A, Van der Goten J, Duym P, Vanholder R. Nephrol Dial Transplant; 1998 Jul; 13(7):1770-5. PubMed ID: 9681726 [Abstract] [Full Text] [Related]
12. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Gaughan WJ, Liss KA, Dunn SR, Mangold AM, Buhsmer JP, Michael B, Burke JF. Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363 [Abstract] [Full Text] [Related]
13. Effect of hyperparathyroidism on response to erythropoietin in children on dialysis. Belsha CW, Berry PL. Pediatr Nephrol; 1998 May; 12(4):298-303. PubMed ID: 9655362 [Abstract] [Full Text] [Related]
19. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A. Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241 [Abstract] [Full Text] [Related]